[Free light chains assay: Indications and methods].
Dosage des chaînes légères libres : indications et méthodes.
Chaines légères libres sériques
Free light chains
Freelite(®)
Gammapathie monoclonale
Indications
Monoclonal gammopathy
Pathophysiology
Physiopathologie
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
24
09
2018
revised:
04
01
2019
accepted:
20
01
2019
pubmed:
14
3
2019
medline:
28
12
2019
entrez:
14
3
2019
Statut:
ppublish
Résumé
Serum free light chains (sFLC) assay is an important marker in plasma cell dyscrasia. It is thus recommended for the diagnosis of monoclonal gammopathy, together with serum protein electrophoresis and immunofixation. sFLC assay has also a prognostic value and is a criterion for treatment response and relapse of some monoclonal gammopathies. Three assays are currently available in France, the gold standard being the Freelite
Identifiants
pubmed: 30862366
pii: S0248-8663(19)30045-1
doi: 10.1016/j.revmed.2019.01.005
pii:
doi:
Substances chimiques
Immunoglobulin Light Chains
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
297-305Informations de copyright
Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.